Evelo Biosciences (EVLO) Short Interest Ratio & Short Volume → BUY ALERT: Billionaires piling into this asset class (From Reagan Gold Group) (Ad) Free EVLO Stock Alerts $0.0006 0.00 (0.00%) (As of 05/30/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Evelo Biosciences Short Interest DataCurrent Short Interest197,000 sharesPrevious Short Interest430,100 sharesChange Vs. Previous Month-54.20%Dollar Volume Sold Short$78,819.70Short Interest Ratio0.3 Days to CoverLast Record DateNovember 30, 2023Outstanding Shares18,980,000 sharesFloat Size9,340,000 sharesShort Percent of Float2.11%Today's Trading Volume0 sharesAverage Trading Volume21,971 sharesToday's Volume Vs. Average0% Short Selling Evelo Biosciences ? Sign up to receive the latest short interest report for Evelo Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartEVLO Short Interest Over TimeEVLO Days to Cover Over TimeEVLO Percentage of Float Shorted Over Time Ad Porter & CompanyKiss of death from Joe BidenI did not consent. You did not consent. It’s in direct violation of the U.S. Constitution but Biden does not care.I have uncovered a bombshell that changes everything… and threatens everything. Evelo Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/30/2023197,000 shares $78,819.70 -54.2%2.1%0.3 $0.40 11/15/2023430,100 shares $191,480.52 +175.0%4.6%0.6 $0.45 10/31/2023156,400 shares $64,280.40 -76.6%1.7%0.4 $0.41 10/15/2023667,800 shares $2.08 million +13.9%7.2%2.6 $3.12 9/30/2023586,400 shares $2.30 million +119.1%6.3%1.1 $3.92 9/15/2023267,700 shares $1.36 million -3.8%2.9%0.4 $5.07 Get the Latest News and Ratings for EVLO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Evelo Biosciences and its competitors with MarketBeat's FREE daily newsletter. 8/31/2023278,200 shares $1.84 million -10.8%3.0%0.3 $6.61 8/15/2023312,000 shares $4.15 million -31.7%3.4%0.4 $13.31 7/31/2023456,600 shares $4.78 million +123.0%4.9%0.6 $10.47 7/15/2023204,800 shares $739,328.00 -47.3%2.2%0.2 $3.61 6/30/2023388,300 shares $25.24 million -78.4%13.9%0.7 $65.00 6/15/20231,800,000 shares $149,220.00 -41.6%N/A0.2 $0.08 5/31/20233,080,000 shares $420,420.00 -13.7%N/A0.8 $0.14 5/15/20233,570,000 shares $505,512.00 +58.7%N/A1 $0.14 4/30/20232,250,000 shares $346,050.00 -10.0%N/A0.6 $0.15 4/15/20232,500,000 shares $418,250.00 -15.8%N/A7.6 $0.17 3/31/20232,970,000 shares $536,679.00 +3.9%N/A10.6 $0.18 3/15/20232,860,000 shares $900,900.00 +4.4%N/A18.1 $0.32 2/28/20232,740,000 shares $1.70 million -22.2%N/A20.7 $0.62 2/15/20233,520,000 shares $2.83 million -21.4%N/A26.5 $0.81 1/31/20234,480,000 shares $4.66 million No ChangeN/A33.8 $1.04 1/15/20234,480,000 shares $6.18 million +2.5%N/A38.5 $1.38 12/30/20224,370,000 shares $7.04 million -1.8%N/A41 $1.61 12/15/20224,450,000 shares $8.23 million +0.5%N/A44.3 $1.85 11/30/20224,430,000 shares $9.26 million -0.7%N/A29 $2.09 11/15/20224,460,000 shares $9.77 million +0.2%8.5%28.6 $2.19 10/31/20224,450,000 shares $9.08 million No ChangeN/A30.6 $2.04 10/15/20224,450,000 shares $9.57 million -2.2%N/A34.1 $2.15 9/30/20224,550,000 shares $9.51 million +13.2%N/A32.5 $2.09 9/15/20224,020,000 shares $8.52 million -1.0%N/A18.8 $2.12 8/31/20224,060,000 shares $8.89 million +2.0%N/A18.9 $2.19 8/15/20223,980,000 shares $10.95 million -3.6%N/A14.9 $2.75 7/31/20224,130,000 shares $8.71 million -1.2%N/A14 $2.11 7/15/20224,180,000 shares $9.20 million -4.1%N/A12.2 $2.20 6/30/20224,360,000 shares $9.20 million -23.9%N/A11.9 $2.11 6/15/20225,730,000 shares $10.43 million -22.5%N/A14.5 $1.82 5/31/20227,390,000 shares $15.52 million -8.1%N/A23.3 $2.10 5/15/20228,040,000 shares $13.27 million -4.2%29.5%26.3 $1.65 4/30/20228,390,000 shares $20.72 million -0.5%30.8%25.1 $2.47 4/15/20228,430,000 shares $21.41 million No Change31.5%25.2 $2.54Buy this small stock before coming AI Tidal Wave (Ad)The internet generated more wealth than any other innovation in history - creating hundreds of thousands of new millionaires in America alone. Now A.I. could do the same. But if you're buying Microsoft or NVIDIA to profit - you're missing the big picture.Get the name and ticker symbol for free - just click here. 3/31/20228,430,000 shares $28.58 million +2.6%N/A0 $3.39 3/15/20228,220,000 shares $23.43 million +0.6%30.9%27.2 $2.85 2/28/20228,170,000 shares $25.57 million +10.0%30.7%28.3 $3.13 2/15/20227,430,000 shares $29.94 million +11.9%27.9%27.2 $4.03 1/31/20226,640,000 shares $31.27 million +6.8%25.0%28.8 $4.71 1/15/20226,220,000 shares $34.33 million +5.4%N/A24.6 $5.52 12/31/20215,900,000 shares $35.81 million +7.3%22.2%20.9 $6.07 12/15/20215,500,000 shares $42.68 million +6.6%20.7%15.5 $7.76 11/30/20215,160,000 shares $44.48 million -5.3%19.4%13.8 $8.62 11/15/20215,450,000 shares $55.97 million +4.2%20.5%14.5 $10.27 10/29/20215,230,000 shares $46.29 million -3.3%19.7%14.5 $8.85 10/15/20215,410,000 shares $43.01 million +11.8%20.4%17.2 $7.95 9/30/20214,840,000 shares $34.07 million +35.2%18.2%15.6 $7.04 9/15/20213,580,000 shares $25.02 million +12.2%13.5%15.7 $6.99 8/31/20213,190,000 shares $36.27 million -1.5%12.0%17.7 $11.37 8/13/20213,240,000 shares $33.66 million -10.5%12.2%18.2 $10.39 7/30/20213,620,000 shares $33.34 million +10.4%13.6%19.8 $9.21 7/15/20213,280,000 shares $36.08 million +19.7%12.4%17.6 $11.00 6/30/20212,740,000 shares $37.65 million +7.9%10.3%13.1 $13.74 6/15/20212,540,000 shares $41.53 million -2.7%9.6%14.1 $16.35 5/28/20212,610,000 shares $35.03 million -13.3%9.8%12.8 $13.42 5/14/20213,010,000 shares $33.14 million +13.6%11.3%13.4 $11.01 4/30/20212,650,000 shares $32.44 million +1.5%9.0%11.3 $12.24 4/15/20212,610,000 shares $29.10 million -17.9%N/A0 $11.15 3/31/20213,180,000 shares $32.98 million +8.2%12.2%11.5 $10.37 3/15/20212,940,000 shares $35.13 million +25.6%11.3%9.6 $11.95 2/26/20212,340,000 shares $31.94 million -11.0%10.3%5.6 $13.65 2/12/20212,630,000 shares $42.79 million +22.9%11.6%6.7 $16.27 1/29/20212,140,000 shares $39.80 million -14.1%9.4%5.5 $18.60 1/15/20212,490,000 shares $34.31 million +18.6%12.8%7.4 $13.78 12/31/20202,100,000 shares $25.33 million +5.0%14.2%6.3 $12.06 12/15/20202,000,000 shares $18.82 million -3.4%13.5%6.8 $9.41 11/30/20202,070,000 shares $10.76 million -0.5%14.0%14.1 $5.20 11/15/20202,080,000 shares $9.44 million +1.5%14.1%14 $4.54 10/30/20202,050,000 shares $8.90 million +7.3%13.9%13.7 $4.34 10/15/20201,910,000 shares $10.16 million +10.4%12.9%11.7 $5.32 9/30/20201,730,000 shares $9.12 million +19.3%11.7%11.1 $5.27 9/15/20201,450,000 shares $7.66 million +5.1%9.8%8.2 $5.28 8/31/20201,380,000 shares $6.13 million +16.0%9.3%8.2 $4.44 8/14/20201,190,000 shares $6.01 million +0.9%8.1%7.9 $5.05 7/31/20201,180,000 shares $4.50 million -2.5%9.7%8 $3.81 7/15/20201,210,000 shares $4.95 million -49.4%10.0%9.8 $4.09 6/30/20202,390,000 shares $12.33 million +32.0%N/A20 $5.16 6/15/20201,810,000 shares $6.93 million +8.4%15.6%22.3 $3.83 5/29/20201,670,000 shares $7.46 million -10.2%14.4%22.6 $4.47 5/15/20201,860,000 shares $8.37 million +4.5%16.0%26.4 $4.50 4/30/20201,780,000 shares $9.86 million +2.9%15.4%22.3 $5.54 4/15/20201,730,000 shares $6.52 million +1.2%15.1%19 $3.77 3/31/20201,710,000 shares $8.86 million +4.0%14.9%18.4 $5.18 3/13/20201,645,000 shares $6.42 million +3.5%14.4%21.8 $3.90Buy this small stock before coming AI Tidal Wave (Ad)The internet generated more wealth than any other innovation in history - creating hundreds of thousands of new millionaires in America alone. Now A.I. could do the same. But if you're buying Microsoft or NVIDIA to profit - you're missing the big picture.Get the name and ticker symbol for free - just click here. 2/28/20201,590,000 shares $5.66 million -0.6%14.0%16.8 $3.56 2/14/20201,600,000 shares $7.50 million -8.6%14.1%16 $4.69 1/31/20201,750,000 shares $9.01 million -11.2%15.1%21.3 $5.15 1/15/20201,970,000 shares $8.45 million +1.6%17.0%27.8 $4.29 12/31/20191,940,000 shares $11.66 million No Change16.7%33.6 $6.01 8/15/20191,534,700 shares $9.59 million +0.1%14.7%38.8 $6.25 EVLO Short Interest - Frequently Asked Questions What is Evelo Biosciences' current short interest? Short interest is the volume of Evelo Biosciences shares that have been sold short but have not yet been closed out or covered. As of November 30th, traders have sold 197,000 shares of EVLO short. 2.11% of Evelo Biosciences' shares are currently sold short. Learn More on Evelo Biosciences' current short interest. What is a good short interest percentage for Evelo Biosciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.11% of Evelo Biosciences' floating shares are currently sold short. Is Evelo Biosciences' short interest increasing or decreasing? Evelo Biosciences saw a drop in short interest in November. As of November 30th, there was short interest totaling 197,000 shares, a drop of 54.2% from the previous total of 430,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Evelo Biosciences' float size? Evelo Biosciences currently has issued a total of 18,980,000 shares. Some of Evelo Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Evelo Biosciences currently has a public float of 9,340,000 shares. How does Evelo Biosciences' short interest compare to its competitors? 2.11% of Evelo Biosciences' shares are currently sold short. Here is how the short interest of companies compare to Evelo Biosciences: Grifols, S.A. (3.10%), LAVA Therapeutics (0.84%), Mainz Biomed (1.75%), NLS Pharmaceutics Ltd. (0.18%), Pharvaris (0.66%), Procaps Group S.A. (0.07%), Qilian International Holding Group Limited (0.68%), Agenus Inc. (15.73%), Incyte Co. (3.36%), Gilead Sciences, Inc. (1.75%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: RTX Co. ($6.17 billion), Canadian Natural Resources Limited ($3.99 billion), T-Mobile US, Inc. ($3.78 billion), Charter Communications, Inc. ($3.37 billion), Coinbase Global, Inc. ($2.89 billion), Suncor Energy Inc. ($2.83 billion), Occidental Petroleum Co. ($2.64 billion), Tractor Supply ($2.31 billion), Royal Caribbean Cruises Ltd. ($1.73 billion), and Rivian Automotive, Inc. ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short Evelo Biosciences stock? Short selling EVLO is an investing strategy that aims to generate trading profit from Evelo Biosciences as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Evelo Biosciences? A short squeeze for Evelo Biosciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of EVLO, which in turn drives the price of the stock up even further. How often is Evelo Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EVLO, twice per month. The most recent reporting period available is November, 30 2023. More Short Interest Resources from MarketBeat Related Companies: Grifols Short Interest LAVA Therapeutics Short Interest Mainz Biomed Short Interest NLS Pharmaceutics Short Interest Pharvaris Short Interest Procaps Group Short Interest Qilian International Holding Group Short Interest Agenus Short Interest Incyte Short Interest Gilead Sciences Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:EVLO) was last updated on 5/31/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersBill Clinton Backing Biden Replacement???The Freeport SocietyBUY ALERT: Billionaires piling into this asset classReagan Gold GroupThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarBuy this small stock before coming AI Tidal WaveChaikin Analytics41 banks launch ‘crypto dollar’Stansberry ResearchDems have chosen Biden replacement?Paradigm PressGold Set to EXPLODE!Gold Safe Exchange Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evelo Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.